Newly launched dementia caregiver training programme by Epoch Elder Care aims to improve care quality: Our Bureau, Mumbai ...

ImmuneSensor begins patient dosing in phase 1 trial of lead cGAS inhibitor drug candidate, IMSB301 to treat inflammatory and autoimmune diseases: Dallas, Texas Thursday, October 1 ...

UK MHRA grants marketing approval for Ipsen’s elafibranor to treat adults with rare liver disease known as PCB: United Kingdom Thursday, October 10, 2024, 15:00 Hrs [IST] The Me ...

Cellipont Bioservices inks agreement with Mongoose for technology transfer to advance MGB-001 TCR-T cell therapy programme: The Woodlands, Texas Thursday, October 10, 2024, 17:00 ...

Symbiosis acquires 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity: Stirling, UK Thursday, October 10, 2024, 14:00 Hrs [IST] Symbios ...

India Postal Service honours Holy Family Hospital’s four decades of compassionate healthcare with special cover stamp release: Our Bureau, Mumbai Thursday, October 10, 2024, 17: ...

NABH to conduct entry-level hospital assessors’ training programme in New Delhi from Oct 22 to 24: Shardul Nautiyal, Mumbai ...

Bayer, MOMA Therapeutics ink collaboration to develop and commercialize small molecule oncology programme: Berlin, Germany Thursday, October 10, 2024, 13:00 Hrs [IST] Bayer and MO ...

Akums Drugs launches dual-action heartburn relief chewable tablets for India: Our Bureau, Mumbai Thursday, October 10, 2024, 15:45 Hrs [IST] Akums Drugs and Pharmaceuticals, large ...

Aerogen and IARC sign strategic MoU to transform respiratory care in India: Our Bureau, Mumbai Thursday, October 10, 2024, 16:30 Hrs [IST] Aerogen, an Ireland-based global leader ...

Sanofi to present data from Beyfortus to treat RSV diseases at IDWeek 2024 annual meeting: Paris Thursday, October 10, 2024, 12:00 Hrs [IST] Sanofi advances its ambition to protec ...

Qinotto, Inc, a central nervous system (CNS) focused biopharmaceutical company discovering novel vehicles to deliver large molecule therapeutics to the brain, announced that it has entered into a ...